Current diagnostic and prognostic markers for breast cancer encompass traditional imaging indicators, TNM tumor stage, hormone receptor status, Her2 expression level which can guide treatment decisions and prognostic assessments. This evidence concerns the gene ERBB2 and neoplasm.